GQR Life Sciences, a leader in total talent solutions for the biopharma industry, is proud to announce a strategic partnership with Nebula, an AI-powered talent platform that takes client service and innovation to the next level. This partnership strengthens GQR Life Sciences' ability to deliver advanced workforce sol…
More than 6 million people in over 60 countries rely on Abbott’s technology to manage their diabetes, and global demand is growing. That’s why we recently expanded our manufacturing capacity with the launch of a new 323,000-square-foot site to produce sensors for FreeStyle Libre 3, the latest generation in our world-l…
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed to foster collaboration, co-development and learning on site with customers and other external innovation partners, ap…
NAI Group, a provider of advanced high-performance interconnect solutions for mission-critical industrial technology, medical, and telecommunications applications, announced the expansion of its manufacturing footprint into Southeast Asia. The new facility, based in Malaysia, is expected to be fully operational in the…
Overlook Industries Inc., a global leader in single-use filler needles and silicone over-molded assemblies, is celebrating its 30th anniversary with a major facility expansion. In June 2023, Overlook procured a 16,000 square-foot building adjacent to its current site, marking a significant step in its growth strategy.…
Emoneeds, a leading digital mental health platform, has announced its strategic hiring initiative aimed at expanding its talented team as part of its growth and commitment to offering top-tier mental health services across India. With a current workforce of 67 employees, including three contractual staff members, Emon…
Abbott marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony attended by An Taoiseach, Simon Harris, TD, and Abbott Chairman and Chief Executive Officer, Robert Ford. The site is a global manufacturing centre of excellence for Abbott's diabetes care business an…
Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lilly and Company (Lilly), announced the establishment of a SGD$42 million Digital Health Innovation Hub in Singapore to accelerate the research and development of AI-powered digital health technologies.…
AstraZeneca announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the growth of the US economy. AstraZ…
Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced it will invest in additional bioconjugation capabilities in Visp (CH). The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing-related infrastructure to the existing b…
Page 33 of 63